References
- Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Paediatrics 2001;108:1275-9. https://doi.org/10.1542/peds.108.6.1275
- Olaciregui I, Hernandez U, Munoz JA, Emparanza JI, Landa JJ. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin. Arch Dis Child 2009;94:501-5. https://doi.org/10.1136/adc.2008.146530
- Van den Bruel A, Thompson MJ, Haj-Hassan T, Stevens R, Moll H. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systemic review. BMJ 2011;342:d3082. https://doi.org/10.1136/bmj.d3082
- Bilavsky E, Yarden-Bilavsky H, Ashkenazi S, Amir J. C-reactive protein as a marker of serious bacterial infections in hospitalized febrile infants. Acta Paediatr 2009;98:1776-80. https://doi.org/10.1111/j.1651-2227.2009.01469.x
- Baraff LJ. Outpatient management of fever in selected infants. N Engl J Med 1994;330:938-9. https://doi.org/10.1056/NEJM199403313301315
- Dagan R, Powell KR, Hall CB, Menegus MA. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr 1985;107:855-60. https://doi.org/10.1016/S0022-3476(85)80175-X
- Sturgeon JP, Zanetti B, Lindo D. C-reactive protein (CRP) levels in neonatal meningitis in England: an analysis of national variations in CRP cut-offs for lumbar puncture. BMC Pediatrics 2018;18:380. https://doi.org/10.1186/s12887-018-1354-x
- Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012;129:1006-15. https://doi.org/10.1542/peds.2012-0541
- Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997;16:735-46. https://doi.org/10.1097/00006454-199708000-00003
- Du Clos TW. Function of C-reactive protein. Ann Med 2000;32:274-8. https://doi.org/10.3109/07853890009011772
- National Institute for Health and Clinical Excellence (NICE). Neonatal infection (early onset): antibiotics for prevention and treatment. Clinical guideline [CG149] [Internet]. Manchester: NICE; 2012 [cited 2019 Dec 14]. http://www.nice.org.uk/guidance/cg149/
- Kelly C, Sohal A, Michael BD, Riordan A, Solomon T, Kneen R, et al. Suboptimal management of central nervous system infections in children: a multi-centre retrospective study. BMC Pediatr 2012;12:145.
- Milcent K, Faesch S, Gras-Le Guen C, Dubos F, Poulalhon C, Badier I, et al. Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr 2016;170:62-9. https://doi.org/10.1001/jamapediatrics.2015.3210
- Woll C, Neuman MI, Aronson PL. Management of the febrile young infant: update for the 21st century. Pediatr Emerg Care 2017;33:748-53. https://doi.org/10.1097/PEC.0000000000001303
- Maniaci V, Dauber A, Weiss S, Nylen E, Becker KL, Bachur R. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 2008;122:701-10. https://doi.org/10.1542/peds.2007-3503
- Khilnani P, Deopujari S, Carcillo J. Recent advances in sepsis and septic shock. Indian J Pediatr 2008;75:821-30. https://doi.org/10.1007/s12098-008-0154-y
- Manzano S, Bailey B, Girodias JB, Galetto-Lacour A, Cousineau J, Delvin E. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial. Am J Emerg Med 2010;28:647-53. https://doi.org/10.1016/j.ajem.2009.02.022
- Gajdos V, Foix L'Helias L, Mollet-Boudjemline A, Perreaux F, Trioche P, Labrune P. Factors predicting serious bacterial infections in febrile infants less than three months old: multivariate analysis. Arch Pediatr 2005;12:397-403. https://doi.org/10.1016/j.arcped.2005.01.005
- Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2009;394:221-6. https://doi.org/10.1007/s00423-008-0432-1
- Rey C, Los Arcos M, Concha A, Medina A, Prieto S, Martinez P, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 2007;33:477-84. https://doi.org/10.1007/s00134-006-0509-7
- Konstantinidis T, Cassimos D, Gioka T, Tsigalou C, Parasidis T, Alexandropoulou I, et al. Can procalcitonin in cerebrospinal fluid be a diagnostic tool for meningitis. J Clin Lab Anal 2015;29:169-74. https://doi.org/10.1002/jcla.21746
- Prasad R, Kapoor R, Mishra OP, Srivastava R, Kant Singh U. Serum procalcitonin in septic meningitis. Indian J Pediatr 2013;80:365-70. https://doi.org/10.1007/s12098-012-0933-3
- Hur M, Moon HW, Yun YM, Kim KH, Kim HS, Lee KM. Comparison of diagnostic utility between procalcitonin and C-reactive protein for the patients with blood culture-positive sepsis. Korean J Lab Med 2009;29:529-35. https://doi.org/10.3343/kjlm.2009.29.6.529
- Kim EK, Lee BS, Lee JA, Jo HS, Park JD, Kim BI, et al. Clinical availability of serum procalcitonin level in the diagnosis of neonatal bacterial infection. J Korean Soc Neonatol 2001;8:211-21.
- Kim NH, Kim JH, Lee TJ. Diagnostic value of serum procalcitonin in febrile infants under 6 months of age for the detection of bacterial infections. Korean J Pediatr Infect Dis 2009;16:142-9. https://doi.org/10.14776/kjpid.2009.16.2.142